With digital innovations and smart technologies in R&D taking the pharmaceutical industry by storm, it is now more important than ever to keep track of industry best practices and strategies.
A major international management consulting firm wanted to get an overview of pharmaceutical industries across six countries. They wanted an in-depth understanding of the government tendering and procurement processes at every stage of the pharma value chain- manufacturing, distribution, and retail, in order to help their strategy team with effective decision-making.
About the client
Our client is an international management consulting firm with specialities across the healthcare and pharmaceutical domains.
Objective and scope
In order to get a better understanding of the pharmaceutical sector and help their strategy team, our client wanted a pharmaceutical benchmarking study conducted across six countries, globally. This list included the US, the UK, India, Japan, France, and Sweden.
They wanted a thorough grasp of the government tendering and procurement process at every stage of the pharmaceutical value chain – manufacturing, distribution, and retail. The client also requested a comparative analysis of the local production, licensing procedures, pharmaceutical market structure, e-sales, and active legal cases, including anti-competitive behavior, patent disputes, and so on, across the target nations.
Solutions and approach
The firm approached Netscribes for its vast research coverage and experience in working with global companies across the pharmaceutical value chain.
Phase 1: Gathering relevant data based on publicly available resources
To provide our client with detailed data on regulatory acts, and related documents published by the government an governmentaffiliated organizations, Netscribes conducted extensive secondary research to collect data from a variety of open and paid data sources, including the following:
- DRG group reports
- NHS reports
- House of Commons reports
- Thomson Reuters Practical Law
- Japan Pharmaceutical Manufacturers Association
- International Trade Administration
- European Medicines Agency
- European Federation of Pharmaceutical Industries and Associations
- US FDA
- Swedish Medical Product Agency, and other whitepapers and journals.
Phase 2: Filling the gaps through primary research
Additionally, telephonic interviews were conducted with industry experts from the regulatory wing of tier I pharmaceutical manufacturers and consultants from relevant regulatory agencies in the target countries. Each interview lasted approximately 40 to 45 minutes.
Benefits
Netscribes provided the client with a detailed benchmarking study, that helped them gain a holistic understanding of the government procurements and tendering process along with drug manufacturing regulations, licensing procedures, e-commerce regulations, market entry and exit barriers, contractual relationships, and anti-trust and competition laws.
